Wang Ruiyang, Cheng Jiuling, Zhang Yuping, Wang Huaqi
The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Henan Institute of Interconnected Intelligent Health, Henan Key Laboratory of Chronic Disease Prevention and Therapy & Intelligent Health Management, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City, China.
Eur J Med Res. 2024 Dec 26;29(1):624. doi: 10.1186/s40001-024-02216-5.
To investigate the risk factors associated with benign central airway stenosis following COVID-19 infection.
The clinical data of 235 patients hospitalized for COVID-19 infection at the First Affiliated Hospital of Zhengzhou University from October 2022 to October 2023 were retrospectively analyzed. Based on the occurrence of postoperative central airway stenosis, the patients were categorized into a stenosis group (118 cases) and a control group (117 cases). The incidence of central airway stenosis following COVID-19 infection was summarized. Univariate and multivariate logistic regression analyses were conducted to identify risk factors associated with central airway stenosis after COVID-19 infection.
Among the 235 patients studied, 118 developed central airway stenosis. The results of the univariate analysis indicated that age, sex, liver function (as measured by alanine aminotransferase and aspartate aminotransferase values), renal function (creatinine values), diabetes mellitus, fungal airway infections, tuberculosis, and nutritional status (albumin values) were identified as risk factors for benign central airway stenosis following COVID-19 infection (P < 0.05). Furthermore, the multivariate analysis revealed that sex, diabetes mellitus, fungal airway infections, tuberculosis, and nutritional status (albumin values) were independent risk factors for benign central airway stenosis after COVID-19 infection (all P < 0.05).
diabetes mellitus, fungal airway infections, tuberculosis, and poor nutritional status may lead to benign central airway stenosis after COVID-19 infection. Proactive preventive measures and close monitoring should be taken to improve the quality of life of patients infected with COVID-19.
探讨新型冠状病毒肺炎(COVID-19)感染后良性中央气道狭窄的相关危险因素。
回顾性分析2022年10月至2023年10月在郑州大学第一附属医院住院治疗的235例COVID-19感染患者的临床资料。根据术后中央气道狭窄的发生情况,将患者分为狭窄组(118例)和对照组(117例)。总结COVID-19感染后中央气道狭窄的发生率。进行单因素和多因素logistic回归分析,以确定COVID-19感染后中央气道狭窄的相关危险因素。
在研究的235例患者中,118例发生中央气道狭窄。单因素分析结果表明,年龄、性别、肝功能(以丙氨酸氨基转移酶和天冬氨酸氨基转移酶值衡量)、肾功能(肌酐值)、糖尿病、气道真菌感染、结核病和营养状况(白蛋白值)被确定为COVID-19感染后良性中央气道狭窄的危险因素(P<0.05)。此外,多因素分析显示,性别、糖尿病、气道真菌感染、结核病和营养状况(白蛋白值)是COVID-19感染后良性中央气道狭窄的独立危险因素(均P<0.05)。
糖尿病、气道真菌感染、结核病和营养状况差可能导致COVID-19感染后良性中央气道狭窄。应采取积极的预防措施并密切监测,以提高COVID-19感染患者的生活质量。